FROM SCIENCE TO PERSONALIZED HEALTHCARE: HOW BASEL'S INNOVATION ECOSYSTEM IS TRANSFORMING PATIENT CARE
Swiss healthtech company Nutrix is transforming preventive healthcare through AI-powered hormone intelligence. Based at Switzerland Innovation Park Basel Area, the company is scaling breakthrough technologies that enable personalized health monitoring beyond traditional clinical settings.
«Switzerland Innovation Park Basel Area has given us access to an exceptional network of experts, partners and innovators. Being part of this ecosystem helps us accelerate the development of technologies that make preventive healthcare more accessible and personalized.»
Co-Founder & CEO, Nutrix
When Maria Hahn founded Nutrix, she set out to tackle a fundamental challenge in healthcare: how to identify health risks earlier and enable more effective prevention. Today, the Basel-based healthtech company is helping shape the future of personalized healthcare through a unique combination of artificial intelligence, biosensors and hormone intelligence. Its mission is to make health monitoring more accessible, actionable and preventive.
At the core of Nutrix’s technology portfolio is gSense, an AI-powered platform that transforms health, lifestyle and laboratory data into personalized recommendations. The company has also developed cortiSense, a non-invasive cortisol monitoring solution that enables users to track stress-related hormonal changes outside traditional clinical settings. Building on this expertise, Nutrix is advancing tSense, an innovative testosterone monitoring technology that earned a CES Innovation Award in 2026, marking the company’s second consecutive recognition at the world’s largest consumer technology event.
Transforming scientific breakthroughs into scalable healthcare solutions requires more than technological innovation. As a resident company at Switzerland Innovation Park Basel Area, Nutrix benefits from direct access to one of the world’s leading life sciences ecosystems. Located on the Novartis Campus, the Park connects startups with researchers, industry experts, healthcare stakeholders and global corporations, creating an environment where innovation can move faster from concept to market.
This ecosystem has helped Nutrix accelerate the development and validation of its technologies while building strategic partnerships and expanding its international reach. Today, the company’s hormone intelligence solutions are being deployed beyond Switzerland, supporting a shift towards more personalized and proactive healthcare. Nutrix exemplifies how Switzerland Innovation Park Basel Area helps ambitious startups translate scientific excellence into global impact, strengthening Switzerland’s position as a leading hub for healthcare innovation.













































